CTRC-AACR San Antonio Breast Cancer Symposium
- 4 Nov 2008The CTRC-AACR San Antonio Breast Cancer Symposium features the latest findings in laboratory, translational and clinical breast cancer research. This year's meeting focuses on new and promising therapeutic approaches, as well as strides being made in diagnosing and preventing breast cancer.
To help you take the best advantage of the symposium's scientific abstracts and related activities, we encourage you to visit www.sabcs.org to view the new press policies developed in partnership with the American Association for Cancer Research (AACR).
The 2008 San Antonio Breast Cancer Symposium (SABCS) will be the first Symposium presented by the CTRC (Cancer Therapy & Research Center) at the University of Texas Health Science Center at San Antonio, AACR and the Baylor College of Medicine. More than 1,000 abstracts will be presented at the symposium, complementing an outstanding program of scientific and educational events.
Highlights:
- Practice-changing data on the role of zolendric acid in late-stage breast cancer
- How changes in breast density can predict outcome with tamoxifen
- Why rest is as important as physical activity in breast cancer prevention
- Recurrence rates among patients with small HER2-positive tumors
- Evaluation of letrozole as adjuvant endocrine therapy
- Phase III trials of new, paradigm-shifting clinical agents like topoisomerase
When:
December 10-14, 2008
Where:
Henry B. Gonzales Convention Center
San Antonio, TX
CTRC-AACR Press Room:
Location: Room 217 A/B, Convention Center
Hours: Wed. 12:00 p.m. to 7:00 p.m.
Thurs. to Sat. 8:00 a.m. – 7 p.m.
Sun. 8:00 a.m. – 12:00 p.m.
E-mail:
Hotel Accommodations:
Housing registration is open. Please visit: http://www.sabcs.org/Housing/Index.asp
Contact/Press Registration:
Jill Byrd
Ph: (210) 450-5550
Fax: (210) 450-1686






Please copy the 5 symbols from this security code image into the box below to submit comment.












